127 related articles for article (PubMed ID: 20407410)
61. Pseudomonas aeruginosa infective endocarditis presenting as bacterial meningitis.
Venkatesan A; Spalding C; Speedie A; Sinha G; Rumbaugh JA
J Infect; 2005 Nov; 51(4):e199-202. PubMed ID: 16291269
[TBL] [Abstract][Full Text] [Related]
62. Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
Ang JY; Abdel-Haq N; Zhu F; Thabit AK; Nicolau DP; Satlin MJ; van Duin D
Antimicrob Agents Chemother; 2016 Oct; 60(10):5627-30. PubMed ID: 27664282
[TBL] [Abstract][Full Text] [Related]
63. Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
Yan LZ; Herrington JD
J Oncol Pharm Pract; 2016 Aug; 22(4):584-90. PubMed ID: 26156260
[TBL] [Abstract][Full Text] [Related]
64. [Infectious endocarditis].
Shah PM
Internist (Berl); 1993 Sep; 34(9):877-84; quiz 884. PubMed ID: 8407207
[No Abstract] [Full Text] [Related]
65. Left-sided Pseudomonas Endocarditis with Disseminated Septic Emboli.
Mohamed AS; Ganga HV; Gaitanis M; Kokkirala AR
R I Med J (2013); 2019 Apr; 102(3):38-41. PubMed ID: 30943671
[TBL] [Abstract][Full Text] [Related]
66. Dual Infection by Burkholderia Cepaciaand Pseudomonas Putida in an Infective Endocarditis Case.
Khan M; Lalani FK; Ikram A; Zaman G; Ahmed P
J Coll Physicians Surg Pak; 2017 Jun; 27(6):367-369. PubMed ID: 28689527
[TBL] [Abstract][Full Text] [Related]
67. [Pseudomonas aeruginosa infections].
Tanaka E
Naika; 1972; 29(2):286-90. PubMed ID: 4622605
[No Abstract] [Full Text] [Related]
68. [Clinical assessment of the risk of bacteremia and the value of skin cultures during Stevens-Johnson syndrome and toxic epidermal necrolysis].
de Prost N; Duong TA; Brun-Buisson C; Roujeau JC
Ann Dermatol Venereol; 2010 Oct; 137(10):651-2. PubMed ID: 20932449
[No Abstract] [Full Text] [Related]
69. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
Cho CH; Lee SB
BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
[TBL] [Abstract][Full Text] [Related]
70. Hospital-acquired, native valve endocarditis caused by Pseudomonas aeruginosa.
Bicanic TA; Eykyn SJ
J Infect; 2002 Feb; 44(2):137-9. PubMed ID: 12076074
[No Abstract] [Full Text] [Related]
71. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
[No Abstract] [Full Text] [Related]
72. Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia.
Fish DN; Kiser TH
Pharmacotherapy; 2013 Oct; 33(10):1022-34. PubMed ID: 23744833
[TBL] [Abstract][Full Text] [Related]
73. Ceftolozane-tazobactam resistance induced in vivo during the treatment of MDR Pseudomonas aeruginosa pneumonia.
Plant AJ; Dunn A; Porter RJ
Expert Rev Anti Infect Ther; 2018 May; 16(5):367-368. PubMed ID: 29727213
[No Abstract] [Full Text] [Related]
74. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Microb Drug Resist; 2005; 11(1):68-74. PubMed ID: 15770098
[TBL] [Abstract][Full Text] [Related]
75. Detection of tricuspid valve vegetations by echocardiography.
Lee CC; Ganguly SN; Magnisalis K; Robin E
Chest; 1974 Oct; 66(4):432-3. PubMed ID: 4369911
[No Abstract] [Full Text] [Related]
76. Macrolides for the treatment of Pseudomonas aeruginosa infections?
Howe RA; Spencer RC
J Antimicrob Chemother; 1997 Aug; 40(2):153-5. PubMed ID: 9301978
[No Abstract] [Full Text] [Related]
77. Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study.
Su TY; Ye JJ; Yang CC; Huang CT; Chia JH; Lee MH
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):52. PubMed ID: 28738848
[TBL] [Abstract][Full Text] [Related]
78. [Laboratory and clinical evaluation of clindamycin].
Sawae Y; Inoue H; Shiraishi M; Fujimura T; Takemori K
Jpn J Antibiot; 1971 Apr; 24(2):51-8. PubMed ID: 4996452
[No Abstract] [Full Text] [Related]
79. Azlocillin in the treatment of serious infection with Pseudomonas aeruginosa.
Eykyn SJ
J Antimicrob Chemother; 1982 May; 9(5):395-403. PubMed ID: 6807951
[No Abstract] [Full Text] [Related]
80. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
